Company Snapshot
- Ticker
- A
- Name
- A
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 39789800000.000000
- Volume
- 2,703,558
- Avg Volume (3M)
- 1,783,116
A
A
Last update recent
140.60
+0.92
(+0.66%)
Market Cap
39789800000.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 6948000000.000000
- EPS
- 4.58
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 0.71%
- Net Income
- 1303000000.000000
- Net Margin
- 18.75%
- Payout Ratio
- 21.64%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 30.54
- Forward P/E
- None
- P/S
- 5.73
- P/B
- 5.90
- Beta
- None
- Debt / Equity
- 0.50
- Current Ratio
- 1.96
- Return on Equity
- 0.19%
- Return on Assets
- 0.10%
Technicals & Returns
- Distance vs 200 DMA
- 13.49%
- 200 DMA
- 123.89
- Distance vs 50 DMA
- -3.22%
- 50 DMA
- 145.28
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; rama Read more
- Name
- A
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Padraig McDonnell
- Employees
- 17,400
- IPO Date
- 1999-11-18
- Phone
- 800 227 9770
- Address
- None
- Website
- https://www.agilent.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Last Payout
2024-07-02 • $0.236
Latest News
Curated headlines from premium sources.
Agilent Technologies, Inc. $A Stock Position Lowered by Balyasny Asset Management L.P.
Balyasny Asset Management L.P. decreased its position in Agilent Technologies, Inc. (NYSE: A) by 11.8% in the undefined quarter, according to the company in it…
Head to Head Comparison: Agilent Technologies (NYSE:A) vs. biote (NASDAQ:BTMD)
biote (NASDAQ: BTMD - Get Free Report) and Agilent Technologies (NYSE: A - Get Free Report) are both medical companies, but which is the superior business? We …
Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
30% of the S&P 500 Is Mag 7 Tech Stocks, but This ETF Refuses to Own a Single One
The Magnificent 7 AI tech stocks have served as the rocket fuel propelling the S&P 500 on its bull run over the past few years.
Agilent (A) International Revenue Performance Explored
Examine Agilent's (A) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Agilent Technologies: Steady As She Goes
Agilent Technologies delivered strong Q4 2025 results, with revenue and EPS beating expectations and robust growth in Life Sciences and Diagnostics segment. Ma…